Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Blood-Derived injection strengthen pelvic floor repair?

NCT ID NCT07746739

Disease control Sponsor: Andalas University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 05, 2026 · Last updated Aug 11, 2026 · Updated 3 times

Summary

This trial tests whether adding platelet-rich plasma (PRP) to standard surgery for pelvic organ prolapse improves pelvic floor muscle strength and reduces the chance of prolapse returning. Forty women with stage II or higher prolapse will be randomly assigned to receive either PRP or a placebo injection during their operation. Pelvic floor strength and prolapse severity will be measured before surgery and eight weeks after.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Platelet-rich plasma (PRP) injection during pelvic organ prolapse surgery
What this could lead to
If effective, PRP could become a standard addition to prolapse surgery, improving pelvic floor strength and lowering the chance of prolapse returning.
What could go wrong
This is a small, early-stage trial with only 40 women, so results may not apply broadly. PRP is generally safe but may cause injection-site discomfort or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Aug 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: women aged ≤65 years with stage II or higher pelvic organ prolapse (POP) who provided written informed consent to participate Exclusion Criteria:a history of gynecologic malignancy, collagen vascular disease, hematological disorders, or diabetes mellitus.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pelvic organ prolapse are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

pelvic organ prolapse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pelvic organ prolapse Pelvic organ prolapse vaginal surgery Platelet rich plasma injection

Contacts and locations

Locations

  • M Djamil Hospital

    Padang, West Sumatera, 25129, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.